// App-Quantinova.ai

: Engineering TIMP-3 for OA therapy

Researchers

Presenter

  • L. Troeberg

Principal Investigators

  • N/A

Medical Centers

  • University of Oxford, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Low-density lipoprotein receptor-related protein 1

  • Matrix metalloproteinase

  • TIMP Metallopeptidase Inhibitor 3

Drug/Treatment

  • TIMP-3 secretion inducer

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved